A survey of The Scientist readers reveals who buys cell-growth products from whom, and why.
A survey of The Scientist readers reveals who buys cell-growth products from whom, and why.
Nanoscale cracks in bone dissipate energy to protect against fracture, a process that appears to be regulated by the interaction of two proteins.
Inducing certain brain patterns extends non-REM sleep in mice.
Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?
Researchers have created a molecule that helps nanoparticles evade immune attack and could improve drug delivery.
Three Silicon Valley entrepreneurs are offering $3 million to scientists demonstrating excellence in biology and medical research.
Disruptions in the interaction between nuclear and mitochondrial DNA can lead to deficiencies in the mitochondrial energy-generating process, affecting fitness.
The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
Protein aggregates in the brains of some people with dementia or motor neuron disease have a surprising origin.